DEVELOPMENT AND VALIDATION OF A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ASSAY FOR THE DETERMINATION OF A FLUORINATED ANALOGUE OF THALIDOMIDE, N-(2,6-DIOXOPIPERIDIN-3-YL)-3,4,5,6-TETRAFLUOROPHTHALAMIC ACID, AND LENALIDOMIDE-Reference-Cited by-同舟云学术

DEVELOPMENT AND VALIDATION OF A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ASSAY FOR THE DETERMINATION OF A FLUORINATED ANALOGUE OF THALIDOMIDE, N-(2,6-DIOXOPIPERIDIN-3-YL)-3,4,5,6-TETRAFLUOROPHTHALAMIC ACID, AND LENALIDOMIDE

Published:2011-01-07 Issue:2 Volume:34 Page:83-92
ISSN:1082-6076
Container-title:Journal of Liquid Chromatography & Related Technologies
language:en
Short-container-title:Journal of Liquid Chromatography & Related Technologies

Author:

Pather Kaveshree¹,Helsby Nuala A.²,Palmer Brian D.¹,Ching Lai-Ming¹

Affiliation:

1. a Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, School of Medicine , University of Auckland , Auckland, New Zealand

2. b Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, School of Medicine , University of Auckland , Auckland, New Zealand

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pharmaceutical Science,Biochemistry,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826076.2010.526853

Reference10 articles.

1. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

2. Treatment of multiple myeloma

3. Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

4. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

5. The evolution of thalidomide and its IMiD derivatives as anticancer agents

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model;Stroke;2018-05

2. Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma;Cancer Chemotherapy and Pharmacology;2014-01-30